Arrow Mark Colorado Holdings LLC Next Cure, Inc. Transaction History

Arrow Mark Colorado Holdings LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$6.74 - $8.02 $1.54 Million - $1.84 Million	-228,855 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$9.81 - $13.88 $4.79 Million - $6.78 Million	-488,502 Reduced 68.1%	228,855 $2.29 Million
Q4 2020 Feb 16, 2021	SELL	$9.47 - $12.43 $55,247 - $72,516	-5,834 Reduced 0.81%	717,357 $7.82 Million
Q3 2020 Nov 16, 2020	SELL	$8.15 - $21.17 $63,773 - $165,655	-7,825 Reduced 1.07%	723,191 $6.36 Million
Q2 2020 Aug 14, 2020	SELL	$21.19 - $40.2 $22,779 - $43,215	-1,075 Reduced 0.15%	731,016 $15.7 Million
Q1 2020 May 15, 2020	SELL	$32.32 - $58.37 $949,723 - $1.72 Million	-29,385 Reduced 3.86%	732,091 $27.1 Million
Q4 2019 Feb 14, 2020	BUY	$25.0 - $92.22 $17.8 Million - $65.6 Million	711,476 Added 1422.95%	761,476 $42.9 Million
Q2 2019 Aug 14, 2019	BUY	$14.16 - $20.64 $708,000 - $1.03 Million	50,000 New	50,000 $749,000

15.9M

Ticker NXTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,748,800
Market Cap $36.4M
Description
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...

Get notified when there are updates to the investment portfolio of Arrow Mark Colorado Holdings LLC, based on Form 13F filings with the SEC.

Stay updated on Arrow Mark Colorado Holdings LLC with notifications on news.